Search Results

Obesity: Pathophysiology and Clinical Management

Authors: Gurevich-Panigrahi, Tatiana; Panigrahi, Soumya; Wiechec, Emilia; Los, Marek

Source: Current Medicinal Chemistry, Volume 16, Number 4, February 2009 , pp. 506-521(16)

Publisher: Bentham Science Publishers

Role of the serotonin transporter in pulmonary arterial hypertension

Authors: Dempsie, Yvonne; MacLean, Margaret R

Source: Expert Review of Clinical Pharmacology, Volume 1, Number 6, November 2008 , pp. 749-757(9)

Publisher: Expert Reviews

Fenfluramines strongly associated with AR, MR, TR and valve surgery

Source: Reactions, Volume 1, Number 1230, 2008-11-29 , pp. 2-2(1)

Publisher: Adis International

Fenfluramines also associated with MR and valve surgery

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 20-20(1)

Publisher: Adis International

The differing mechanisms of action of anti-obesity agents determines their varying impact on the cardiovascular system

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 8, August 2008 , pp. 19-21(3)

Publisher: Adis International

Impact of Weight-Loss Medications on the Cardiovascular System: Focus on Current and Future Anti-Obesity Drugs

Authors: Drolet, Benoit; Simard, Chantale; Poirier, Paul

Source: American Journal of Cardiovascular Drugs, Volume 7, Number 4, 2007 , pp. 273-288(16)

Publisher: Adis International

Dexfenfluramine/fenfluramine: Valvular heart disorders: case report

Source: Reactions, Volume 1, Number 1155, 2007-06-09 , pp. 9-9(1)

Publisher: Adis International

Functions of serotonin in hypoxic pulmonary vascular remodeling

Authors: Esteve, Juan; Launay, Jean-Marie; Kellermann, Odile; Maroteaux, Luc

Source: Cell Biochemistry and Biophysics, Volume 47, Number 1, February 2007 , pp. 33-43(11)

Publisher: Humana Press

The effects of dexfenfluramine administration on brain serotonin immunoreactivity and lipid peroxidation in mice

Authors: Coşkun, Ş.; Gönül, B.; Özer, Ç.; Erdoğan, D.; Elmas, Ç.

Source: Cell Biology and Toxicology, Volume 23, Number 2, March 2007 , pp. 75-82(8)

Publisher: Springer

Serotonergic Drugs: Effects on Appetite Expression and Use for the Treatment of Obesity

Authors: Halford, Jason C.G.; Harrold, Joanne A.; Boyland, Emma J.; Lawton, Clare L.; Blundell, John E.

Source: Drugs, Volume 67, Number 1, 2007 , pp. 27-55(29)

Publisher: Adis International

Heart Failure Induced by Non-Cardiac Drugs

Authors: Slørdal, Lars; Spigset, Olav

Source: Drug Safety, Volume 29, Number 7, 2006 , pp. 567-586(20)

Publisher: Adis International

Chronic Treatment with Either Dexfenfluramine or Sibutramine in Diet-Switched Diet-Induced Obese Mice

Source: Endocrine, Volume 29, Number 2, April 2006 , pp. 375-382(8)

Publisher: Humana Press

Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction

Author: Gadde, Kishore M.

Source: Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5, Number 6, December 2005 , pp. 549-556(8)

Publisher: Bentham Science Publishers

Effects of dexfenfluramine on serotonin levels of mice ileum, contractility, glutathione and malondialdehyde level

Authors: Özer, Çiüdem; Gönül, Bilge; Elmas, Çiüdem; Erdoüan, Deniz; Ercan, Z.

Source: Molecular and Cellular Biochemistry, Volume 280, Numbers 1-2, December 2005 , pp. 151-157(7)

Publisher: Springer

US FDA: rigid, yet loose, in the approval process

Source: Inpharma, Volume 1, Number 1505, 2005-09-17 , pp. 3-3(1)

Publisher: Adis International

Diabesity: Are Weight Loss Medications Effective?

Authors: Halpern Alfredo; Mancini Marcio C.

Source: Treatments in Endocrinology, Volume 4, Number 2, 2005 , pp. 65-74(10)

Publisher: Adis International

Effects of the sibutramine therapy on pulmonary artery pressure in obese patients

Authors: Guven, A.; Koksal, N.; Cetinkaya, A.; Sokmen, G.; Ozdemir, R.

Source: Diabetes, Obesity and Metabolism, Volume 6, Number 1, January 2004 , pp. 50-55(6)

Publisher: Blackwell Publishing

Treatment of obesity: an update on anti-obesity medications

Authors: Halpern, A.; Mancini, M. C.

Source: Obesity Reviews, Volume 4, Number 1, February 2003 , pp. 25-42(18)

Publisher: Blackwell Publishing

High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy

Authors: Unger, Philippe; Nortier, Joëlle; Muniz Martinez, Marie-Carmen; Plein, Danièle; Vandenbossche, Jean-Luc; Vereerstraeten, Pierre; Vanherweghem, Jean-Louis

Source: Nephrology Dialysis Transplantation, Volume 18, Number 5, May 2003 , pp. 906-910(5)

Publisher: Oxford University Press

The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux

Authors: Johnson G.J.; Leis L.A.; Dunlop P.C.; Weir E.K.

Source: Journal of Thrombosis and Haemostasis, Volume 1, Number 12, December 2003 , pp. 2663-2668(6)

Publisher: Blackwell Publishing